TWI
WX

Thomas White International’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Thomas White International’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-430,986
Closed -$18.6M – 338
2015
Q3 		$18.6M Sell
430,986
-21,472
-5% -$906K 2.79% 2
2015
Q2 		$19.1M Sell
452,458
-22,236
-5% -$938K 2.55% 5
2015
Q1 		$18.4M Buy
474,694
+9,768
+2% +$376K 2.58% 4
2014
Q4 		$15.7M Sell
464,926
-73,286
-14% -$2.59M 2.15% 6
2014
Q3 		$18.8M Buy
538,212
+67,443
+14% +$2.31M 2.73% 3
2014
Q2 		$15.5M Buy
470,769
+426,977
+975% +$14.6M 2.16% 3
2014
Q1 		$1.61M Buy
43,792
+19,543
+81% +$717K 0.23% 126
2013
Q4 		$931K Buy
24,249
+7,425
+44% +$234K 0.13% 130
2013
Q3 		$461K Buy
+16,824
New +$399K 0.07% 149

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Thomas White International's WX Position: Q4 2015 in Review

Thomas White International sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 430,986 shares — an estimated $18.6M sold.

Thomas White International first reported a position in WX in Q3 2013 and held it in 9 quarters. The position peaked at $19.1M in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Thomas White International reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Thomas White International sold 430,986 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $18.6M.
  • Thomas White International first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 9 quarters.
  • Thomas White International's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $19.1M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Thomas White International's 13F filing for Q4 2015, filed 12 Feb 2016.